MyAverix Finance
F · Healthcare
Pharma Mar SAU (PMRA)
Biotechnology
Pharma Mar SAU (PMRA) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-03-30, reported market cap is $1.53B, P/E ratio is 20.53, net margin is 33.9%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for PMRA
Pharma Mar SAU (PMRA) — FAQ
What is Pharma Mar SAU's market cap?
Pharma Mar SAU (PMRA) has a reported market cap of $1.53B (data as of 2026-03-30).
What is PMRA's P/E ratio?
The price-to-earnings (P/E) ratio for Pharma Mar SAU (PMRA) is 20.53 (data as of 2026-03-30).
Does Pharma Mar SAU pay a dividend?
Dividend yield is not available in the current snapshot for Pharma Mar SAU (PMRA). Check the MyAverix Finance app for the latest dividend data.
What sector is Pharma Mar SAU in?
Pharma Mar SAU (PMRA) is classified in the Healthcare sector (Biotechnology industry).
What exchange is PMRA listed on?
PMRA is listed on F.
What is Pharma Mar SAU's net margin?
Pharma Mar SAU (PMRA) reports a net margin of 33.9% (data as of 2026-03-30).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.